Home
/
Sabra Health Care REIT, Inc.
/
Financials
/
Quarterly
Sabra Health Care REIT, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Sabra Health Care REIT, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$190.04M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$189.15M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$183.54M
May 5, 2025
Q3
2025
Sep 30, 2024
$178.00M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$176.14M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$166.75M
May 5, 2025
Q3
2024
Sep 30, 2023
$161.63M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$161.17M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$161.32M
May 8, 2024
Q3
2023
Sep 30, 2022
$140.76M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$155.96M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$163.11M
May 3, 2023
Q3
2022
Sep 30, 2021
$128.59M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$152.93M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$152.37M
May 4, 2022
Q3
2021
Sep 30, 2020
$143.25M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$153.92M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$149.35M
May 5, 2021
Q3
2020
Sep 30, 2019
$149.83M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$219.37M
Aug 5, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$92.02M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$78.99M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$77.45M
May 5, 2025
Q3
2025
Sep 30, 2024
$73.75M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$67.94M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$66.03M
May 5, 2025
Q3
2024
Sep 30, 2023
$59.75M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$58.43M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$56.72M
May 8, 2024
Q3
2023
Sep 30, 2022
$47.61M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$44.14M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$42.23M
May 3, 2023
Q3
2022
Sep 30, 2021
$39.82M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$39.12M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$36.04M
May 4, 2022
Q3
2021
Sep 30, 2020
$39.34M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$38.58M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$39.98M
May 5, 2021
Q3
2020
Sep 30, 2019
$36.41M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$36.07M
Aug 5, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$22.54M
Nov 5, 2025
Q2
2025
Jun 30, 2025
$65.54M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$40.30M
May 5, 2025
Q3
2025
Sep 30, 2024
$29.79M
Nov 5, 2025
Q2
2025
Jun 30, 2024
$23.98M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$26.25M
May 5, 2025
Q3
2024
Sep 30, 2023
($15.10M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
$21.19M
Aug 7, 2024
Q1
2024
Mar 31, 2023
($9.49M)
May 8, 2024
Q3
2023
Sep 30, 2022
($50.06M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
$16.81M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$40.60M
May 3, 2023
Q3
2022
Sep 30, 2021
$10.22M
Nov 7, 2022
Q2
2022
Jun 30, 2021
($132.57M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
$33.45M
May 4, 2022
Q3
2021
Sep 30, 2020
$36.46M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$29.62M
Aug 4, 2021
Q3
2019
Sep 30, 2019
$23.28M
Oct 30, 2019
Q2
2019
Jun 30, 2019
$83.68M
Aug 7, 2019
Q1
2019
Mar 31, 2019
($77.70M)
May 8, 2019